T Cell Nouveau
Clinical stage biopharmaceutical company with novel TCR like CAR-T cell therapy for solid tumors at affordable price
1 employees · est. 2021 · Tokyo, Japan
Zelluna Immunotherapy
Developing allogeneic TCR-NK therapies for solid tumors
25 employees · est. 2016 · Oslo, Norway
Zelluna Immunotherapy is the older company (2021 vs 2016); Zelluna Immunotherapy is the larger of the two.
Side-by-Side Comparison
| Metric | T Cell Nouveau | Zelluna Immunotherapy |
|---|---|---|
| Founded | ||
| Founded | 2021 | 2016 older |
| Headquarters | ||
| Headquarters | Tokyo, Japan | Oslo, Norway |
| Employees | ||
| Employees | 1 | 25 larger |
| Industry | ||
| Industry | Biopharma, Biotechnology | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Not tracked yet | Series Unknown |
| Total Funding | ||
| Total Funding | Not tracked yet | $7.50M |
| Funding Rounds | ||
| Funding Rounds | Not tracked yet | 4 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical Company, TCR-T Cell Therapy, CAR-T Cell Therapy, Immunotherapy, Solid Tumors, Oncoimmunotherapy, Oncology, Cell Therapy, Cancer Therapy, Neoantigen, MAGEA4, PRAME, Head And Neck Cancer, HLA02, Cancer Vaccine | Immunotherapy, Cancer Treatment, Adoptive Cell Therapy, T Cell Receptor Technologies, Solid Tumors, Biopharmaceutical, Cellular Therapy, Allogeneic TCR-NK Therapies, GMP Facilities, Oslo Cancer Cluster, Norwegian Radium Hospital, Research And Development, Immunooncology, Norwegian Biotechnology |
| Website | ||
| Website | tcellnouveau.com | zelluna.com |
About T Cell Nouveau
T Cell Nouveau is a clinical stage biopharmaceutical company based in Japan that aims to revolutionize cancer treatment. Their mission is to provide affordable TCR like CAR-T cell therapies for common cancers, making it accessible to common people. The company's proprietary technology, originating f...
About Zelluna Immunotherapy
Zelluna is a Norway-based biotechnology company founded in 2016. The company is focused on pioneering allogeneic T cell receptor (TCR) guided natural killer (NK) cell immunotherapies for the treatment of solid cancers. Zelluna's slogan "Developing allogeneic TCR-NK therapies for solid tumors" encaps...
We will tell you when either one moves
BounceWatch watches T Cell Nouveau and Zelluna Immunotherapy for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at T Cell Nouveau and Zelluna Immunotherapy — by email.
Frequently Asked Questions
Compare T Cell Nouveau with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at T Cell Nouveau on 12 Sep 2024, and Zelluna Immunotherapy on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.